United States Pharma Ophthalmic Market Report 2016

December 2016 | 100 pages | ID: U960381D6B1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pharma Ophthalmic

Revenue, means the sales value of Pharma Ophthalmic

This report studies sales (consumption) of Pharma Ophthalmic in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Allergan
• Roche
• Valeant
• Regeneron
• Santen
• Bayer
• Pfizer
• Senju
• Akorn

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Pharma Ophthalmic in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Pharma Ophthalmic Market Report 2016

1 PHARMA OPHTHALMIC OVERVIEW

1.1 Product Overview and Scope of Pharma Ophthalmic
1.2 Classification of Pharma Ophthalmic
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pharma Ophthalmic
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pharma Ophthalmic (2011-2021)
  1.4.1 United States Pharma Ophthalmic Sales and Growth Rate (2011-2021)
  1.4.2 United States Pharma Ophthalmic Revenue and Growth Rate (2011-2021)

2 UNITED STATES PHARMA OPHTHALMIC COMPETITION BY MANUFACTURERS

2.1 United States Pharma Ophthalmic Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pharma Ophthalmic Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pharma Ophthalmic Average Price by Manufactures (2015 and 2016)
2.4 Pharma Ophthalmic Market Competitive Situation and Trends
  2.4.1 Pharma Ophthalmic Market Concentration Rate
  2.4.2 Pharma Ophthalmic Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PHARMA OPHTHALMIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Pharma Ophthalmic Sales and Market Share by Type (2011-2016)
3.2 United States Pharma Ophthalmic Revenue and Market Share by Type (2011-2016)
3.3 United States Pharma Ophthalmic Price by Type (2011-2016)
3.4 United States Pharma Ophthalmic Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PHARMA OPHTHALMIC SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Pharma Ophthalmic Sales and Market Share by Application (2011-2016)
4.2 United States Pharma Ophthalmic Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PHARMA OPHTHALMIC MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Pharma Ophthalmic Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Allergan
  5.2.2 Pharma Ophthalmic Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Allergan Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Roche
  5.3.2 Pharma Ophthalmic Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Roche Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Valeant
  5.4.2 Pharma Ophthalmic Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Valeant Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Regeneron
  5.5.2 Pharma Ophthalmic Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Regeneron Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Santen
  5.6.2 Pharma Ophthalmic Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Santen Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Bayer
  5.7.2 Pharma Ophthalmic Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Bayer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Pfizer
  5.8.2 Pharma Ophthalmic Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Pfizer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Senju
  5.9.2 Pharma Ophthalmic Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Senju Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Akorn
  5.10.2 Pharma Ophthalmic Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Akorn Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 PHARMA OPHTHALMIC MANUFACTURING COST ANALYSIS

6.1 Pharma Ophthalmic Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pharma Ophthalmic

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Pharma Ophthalmic Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pharma Ophthalmic Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PHARMA OPHTHALMIC MARKET FORECAST (2016-2021)

10.1 United States Pharma Ophthalmic Sales, Revenue Forecast (2016-2021)
10.2 United States Pharma Ophthalmic Sales Forecast by Type (2016-2021)
10.3 United States Pharma Ophthalmic Sales Forecast by Application (2016-2021)
10.4 Pharma Ophthalmic Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pharma Ophthalmic
Table Classification of Pharma Ophthalmic
Figure United States Sales Market Share of Pharma Ophthalmic by Type in 2015
Table Application of Pharma Ophthalmic
Figure United States Sales Market Share of Pharma Ophthalmic by Application in 2015
Figure United States Pharma Ophthalmic Sales and Growth Rate (2011-2021)
Figure United States Pharma Ophthalmic Revenue and Growth Rate (2011-2021)
Table United States Pharma Ophthalmic Sales of Key Manufacturers (2015 and 2016)
Table United States Pharma Ophthalmic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pharma Ophthalmic Sales Share by Manufacturers
Figure 2016 Pharma Ophthalmic Sales Share by Manufacturers
Table United States Pharma Ophthalmic Revenue by Manufacturers (2015 and 2016)
Table United States Pharma Ophthalmic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pharma Ophthalmic Revenue Share by Manufacturers
Table 2016 United States Pharma Ophthalmic Revenue Share by Manufacturers
Table United States Market Pharma Ophthalmic Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pharma Ophthalmic Average Price of Key Manufacturers in 2015
Figure Pharma Ophthalmic Market Share of Top 3 Manufacturers
Figure Pharma Ophthalmic Market Share of Top 5 Manufacturers
Table United States Pharma Ophthalmic Sales by Type (2011-2016)
Table United States Pharma Ophthalmic Sales Share by Type (2011-2016)
Figure United States Pharma Ophthalmic Sales Market Share by Type in 2015
Table United States Pharma Ophthalmic Revenue and Market Share by Type (2011-2016)
Table United States Pharma Ophthalmic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pharma Ophthalmic by Type (2011-2016)
Table United States Pharma Ophthalmic Price by Type (2011-2016)
Figure United States Pharma Ophthalmic Sales Growth Rate by Type (2011-2016)
Table United States Pharma Ophthalmic Sales by Application (2011-2016)
Table United States Pharma Ophthalmic Sales Market Share by Application (2011-2016)
Figure United States Pharma Ophthalmic Sales Market Share by Application in 2015
Table United States Pharma Ophthalmic Sales Growth Rate by Application (2011-2016)
Figure United States Pharma Ophthalmic Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Pharma Ophthalmic Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Pharma Ophthalmic Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Pharma Ophthalmic Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharma Ophthalmic Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Pharma Ophthalmic Sales Market Share (2011-2016)
Table Santen Basic Information List
Table Santen Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Pharma Ophthalmic Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Pharma Ophthalmic Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Pharma Ophthalmic Sales Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Senju Pharma Ophthalmic Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Pharma Ophthalmic Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharma Ophthalmic
Figure Manufacturing Process Analysis of Pharma Ophthalmic
Figure Pharma Ophthalmic Industrial Chain Analysis
Table Raw Materials Sources of Pharma Ophthalmic Major Manufacturers in 2015
Table Major Buyers of Pharma Ophthalmic
Table Distributors/Traders List
Figure United States Pharma Ophthalmic Production and Growth Rate Forecast (2016-2021)
Figure United States Pharma Ophthalmic Revenue and Growth Rate Forecast (2016-2021)
Table United States Pharma Ophthalmic Production Forecast by Type (2016-2021)
Table United States Pharma Ophthalmic Consumption Forecast by Application (2016-2021)